The factors such as better performance than Endoscopic Submucosal Dissection, less time to spend at hospital can be the major driver in global market.
New York, NY -- (SBWIRE) -- 02/10/2017 -- Endoscopic mucosal resection is advance technique for superficial gastrointestinal cancers that can avoid the need of open surgery. Endoscopic mucosal resection was founded in Japan for the treatment of early gastric cancer. Cancerous or other abnormal lesions found in the digestive tract can also be eliminate by using endoscopic mucosal resection. A long and narrow tube equipped with a light, video camera and other instruments are used to perform the endoscopic mucosal resection. While performing endoscopic mucosal resection for upper digestive tract, the endoscope is injected from mouth or nose and then it passed down through the throat. During the end of process endoscope is guided to the anus for removal of lesion. Endoscopic mucosal resection is non-surgical theory which is less invasive and extremely safe for treatment of esophageal cancers. It is also very safe and effective method for treatment of adenocarcinoma. The underwater technique for endoscopic mucosal resection found to be more effective than other technique.
A Sample of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/samples/13693
The factors such as better performance than Endoscopic Submucosal Dissection, less time to spend at hospital can be the major driver in global market. Endoscopic mucosal resection do not require any special kit for treatment which is again a major advantage of EMR in global market. Endoscopic mucosal resection technique can be commonly combined with band ligation and snare polypectomy which has good impact in the market. Deep sub-mucosal invasive cancer can also treated using endoscopic mucosal resection technique which has increased its demand in global market. This technique also include high risk factor and it should only be performed by experienced and trained endoscopists only which can restrain growth of endoscopic mucosal resection in global market. The risk factor of endoscopic mucosal resection involve bleeding, puncture of digestive tract or narrowing of esophagus might affect the uptake of EMR.
The global market of endoscopic mucosal resection can be segmented on the basis on technique used, indication and geography.
Based on technique used endoscopic mucosal market is segmented into following:
Suck and cut (suction)
Lift and cut (non-suction)
Based on indication endoscopic mucosal market is segmented into following:
Oesophageal squamous dysplasia
Based on geographical region endoscopic mucosal resection market can be segmented as following:
Endoscopic mucosal resection has shown remarkable impact in the global market. This technology has changed the perspective of detecting the diseases which has gain attention in the global market. Increasing aging population worldwide suffering from diseases such as gastro-esophageal and gastrointestinal cancer will increase the demand of endoscopic mucosal resection. But the high prices of the endoscopic device and less number of trained endoscopist may obstruct the global market. The research on endoscopic devices for mucosal resection have not grant any fund from any funding agency or non-profit organization.
The market of endoscopic mucosal resection is dominated by North America. This market is then followed by Europe and Asia Pacific. Asia Pacific region is fastest growing market in endoscopic muscular resection. Brazil, China, India and Japan have shown as emerging growth in the market of endoscopic device for mucosal resection in Asia Pacific region.
Request to View Tables of Content @ http://www.persistencemarketresearch.com/toc/13693
Some major key manufacturer of endoscopic mucosal resection devices in global market include Ethicon, Inc., Olympus Corporation, Fujifilm Holding Corporation, Boston Scientific Corporation, and Pentax Medical Corporation. Other prominent player in global market are Stryker Corporation (U.S.). KARL STORZ GmBH (Germany), Smith & Nephew plc., Medtronic plc., Richard Wolf GmBH, Conmed Corporation, and Cook Medical Incorporated, Covidien, gMed, US Endoscopy Group, Frontier Healthcare.